Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Jul 27, 2025 | Diamond Hill International | 11.7% | 16.1% | 7451 JP, 8058 JP, AIBG ID, BABA, BNZL LN, GXI GR, HNAL IN, M5W GR, TSCO, TSM, UCB BB | capital returns, diversification, Governance, international, Intrinsic Value | The letter emphasizes intrinsic value investing in non-U.S. equities trading at discounts to long-term fundamentals. Corporate governance reform, capital returns, and balance sheet strength are key drivers of upside. Regional diversification provides exposure to differentiated economic cycles. | HAL IN |
View |
| 2025 Q1 | Mar 31, 2025 | PGIM Jennison Global Opportunities Fund | -11.1% | -11.1% | 1810 HK, IOT, ISRG, SE, SHOP, UCB BB, VRTX | - | View | ||
| 2024 Q4 | Dec 31, 2024 | Hardman Johnston International Equity | -3.3% | 13.4% | 8750 JP, AZN LN, MC FP, MELI, NEX FP, NOD NO, NVO, SDZ SW, STAN LN, TEAM, TSM, UCB BB | - | View | ||
| 2025 Q3 | Oct 21, 2025 | Hardman Johnston International Equity | 8.5% | 36.2% | 6501 JP, 7269 JP, DTE GR, HDFCB IN, ICICIBC IN, IFX GR, MELI, NVO, PRX NA, PRY IM, SDZ SW, STM, TEAM, TSM, UCB BB | AI, Europe, healthcare, International Equities, semiconductors | The fund benefited from strong stock selection in Europe and Asia, led by AI-related semiconductor names like TSMC and STMicroelectronics. Healthcare and consumer discretionary sectors also contributed, while financials and Japan detracted. The outlook highlights opportunity in undervalued international equities amid tariff normalization and AI-led productivity investment. | SUZUKI PROS SDZ UCB |
View |
| 2025 Q1 | Mar 31, 2025 | Artisan International Fund | 9.3% | 9.3% | 012450 KS, 7182 JP, AI FP, ARGX BB, DTE GR, TCEHY, TME, UCB BB | - | View | ||
| 2023 Q4 | Jan 2, 2024 | Diamond Hill International | 5.7% | 12.4% | 005930 KS, 0Q0J LN, 4503 JP, 8GC SW, ASAZY, CVE, DNOPY, UCB BB | - | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | Fund Letters | Mark L. Yockey | UCB SA | Financials | Biotechnology | Bull | Shanghai Stock Exchange | growth, Immunology, Keywords: biologics, Margins, Neurology, pipeline | View Pitch |
| Nov 29, 2025 | Fund Letters | Mark L. Yockey | UCB SA | Financials | Pharmaceuticals | Bull | Shanghai Stock Exchange | Catalysts, dermatology, guidance, Neurology, operating leverage, Peak-sales, pipeline | View Pitch |
| Nov 29, 2025 | Fund Letters | Elisa Mazen | UCB SA | Financials | Biotechnology | Bull | Shanghai Stock Exchange | Biotech, growth, Immunology, Margins, Neurology, pipeline, valuation | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||